1. Autophagy and apoptosis cascade: which is more prominent in neuronal death?
   Rohan Gupta et al, 2021, Cellular and Molecular Life Sciences CrossRef
2. A multifaceted evaluation of microgliosis and differential cellular dysregulation of mammalian target of rapamycin signaling in neuronopathic Gaucher disease
   Zhenting Zhang et al, 2022, Frontiers in Molecular Neuroscience CrossRef
3. Decreased expression of protein O-linked mannose β-1,2-N-acetylglucosaminyltransferase 1 contributes to Alzheimer’s disease-like pathologies
   Yuxue Feng et al, 2022, Journal of Neurophysiology CrossRef
4. Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy
   Si-Jia Hou et al, 2023, Clinical Interventions in Aging CrossRef
5. Inhalation exposure-induced toxicity and disease mediated via mTOR dysregulation
   Akshada Shinde et al, 2024, Experimental Biology and Medicine CrossRef
6. Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic
   Shweta Tripathi et al, 2024, Neurochemical Research CrossRef
7. All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease
   Kwok-Fai So et al, 2022, Neural Regeneration Research CrossRef
8. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy
   Hao Zhang et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef
9. Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer’s therapy
   Magham Sai Varshini et al, 2024, Journal of Drug Targeting CrossRef
10. Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
    Jeffrey L. Cummings et al, 2023, Drugs CrossRef